Knockdown of cytosolic 5′-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 8, 2008, Pages 1529-1535

  Careddu, Maria Giovanna ^a,b   Allegrini, Simone ^b   Pesi, Rossana ^a   Camici, Marcella ^a   Garcia Gil, Mercedes ^a   Tozzi, Maria Grazia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

ADF; Apoptosis; cN II; Cytosolic 5 nucleotidase; Purine analogs; RNAi; shRNA

Indexed keywords

5' NUCLEOTIDASE; CASPASE 3; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; CELL FUNCTION; CELL METABOLISM; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

5'-NUCLEOTIDASE; ADENOVIRIDAE; ANIMALS; APOPTOSIS; ASTROCYTOMA; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; PURINES; RATS; RNA INTERFERENCE;

VERTEBRATA;

EID: 46549084491     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.03.018     Document Type: Article

References (42)

1. Allegrini S., Scaloni A., Careddu M.G., Cuccu G., D'Ambrosio C., Pesi R., Camici M., Ferrara L., and Tozzi M.G. Mechanistic studies on bovine cytosolic 5′-nucleotidase II, an enzyme belonging to the HAD superfamily. Eur. J. Biochem. 271 (2004) 4881-4891
2. Hunsucker S.A., Mitchell B.S., and Spychala J. The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther. 107 (2005) 1-30
3. Bianchi V., and Spychala J. Mammalian 5′-nucleotidases. J. Biol. Chem. 278 (2003) 46195-46198
4. Itoh R., and Kimura K. IMP-GMP 5′-nucleotidase in reptiles: occurrence and tissue distribution in a crocodile and three species of lizards. Comp Biochem. Physiol., B. 142 (2005) 107-112
5. Zimmermann H. 5′-nucleotidase: molecular structure and functional aspects. Biochem. J. 285 Pt 2 (1992) 345-365
6. Banditelli S., Baiocchi C., Pesi R., Allegrini S., Turriani M., Ipata P.L., Camici M., and Tozzi M.G. The phosphotransferase activity of cytosolic 5′-nucleotidase: a purine analog phosphorylating enzyme. Int. J. Biochem. Cell Biol. 2 (1996) 711-720
7. Johnson M.A., and Fridland A. Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36 (1989) 291-295
8. Allegrini S., Scaloni A., Ferrara L., Pesi R., Pinna P., Sgarrella F., Camici M., Eriksson S., and Tozzi M.G. Bovine cytosolic 5′-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate. J. Biol. Chem. 276 (2001) 33526-33532
9. Pesi R., Turriani M., Allegrini S., Scolozzi C., Camici M., Ipata P.L., and Tozzi M.G. The bifunctional cytosolic 5′-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys. 312 (1994) 75-80
10. Pesi R., Baiocchi C., Tozzi M.G., and Camici M. Synergistic action of ADP and 2,3-bisphosphoglycerate on the modulation of cytosolic 5′-nucleotidase. Biochim. Biophys. Acta. 1294 (1996) 191-194
11. Pinto R.M., Canales J., Gunther Sillero M.A., and Sillero A. Diadenosine tetraphosphate activates cytosol 5′-nucleotidase. Biochem. Biophys. Res. Commun. 138 (1986) 261-267
12. Itoh R., Echizen H., Higuchi M., Oka J., and Yamada K. A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5′-nucleotidase. Comp. Biochem. Physiol. B. 103 (1992) 153-159
13. Tozzi M.G., Camici M., Pesi R., Allegrini S., Sgarrella F., and Ipata P.L. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5′-nucleotidase. Arch Biochem Biophys 291 (1991) 212-217
14. Itoh R. IMP-GMP 5′-nucleotidase. Comp. Biochem. Physiol. B. 105 (1993) 13-19
15. Keller P.M., McKee S.A., and Fyfe J.A. Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation. J. Biol. Chem. 260 (1985) 8664-8667
16. Turriani M., Pesi R., Nardone A., Turchi G., Sgarrella F., Ipata P.L., and Tozzi M.G. Cytosolic 5′-nucleotidase/nucleoside phosphotransferase: a nucleoside analog activating enzyme?. J. Biochem. Toxicol. 9 (1994) 51-57
17. Feng J.Y., Parker W.B., Krajewski M.L., Deville-Bonne D., Veron M., Krishnan P., Cheng Y.C., and Borroto-Esoda K. Anabolism of amdoxovir: phosphorylation of dioxolane guanosine and its 5′-phosphates by mammalian phosphotransferases. Biochem. Pharmacol. 68 (2004) 1879-1888
18. Dumontet C., Fabianowska-Majewska K., Mantincic D., Callet Bauchu E., Tigaud I., Gandhi V., Lepoivre M., Peters G.J., Rolland M.O., Wyczechowska D., Fang X., Gazzo S., Voorn D.A., Vanier-Viornery A., and MacKey J. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br. J. Haematol. 106 (1999) 78-85
19. Schirmer M., Stegmann A.P., Geisen F., and Konwalinka G. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5′-nucleotidase activity. Exp Hematol 26 (1998) 1223-1228
20. Galmarini C.M., Jordheim L., and Dumontet C. Role of IMP-selective 5′-nucleotidase (cN-II) in hematological malignancies. Leuk. Lymphoma 44 (2003) 1105-1111
21. Galmarini C.M., Thomas X., Graham K., El Jafaari A., Cros E., Jordheim L., Mackey J.R., and Dumontet C. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br. J. Haematol. 122 (2003) 53-60
22. Galmarini C.M., Mackey J.R., and Dumontet C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 3 (2002) 415-424
23. Galmarini C.M., Graham K., Thomas X., Calvo F., Rousselot P., El Jafaari A., Cros E., Mackey J.R., and Dumontet C. Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 98 (2001) 1922-1926
24. Jordheim L.P., Cros E., Galmarini C.M., Dumontet C., Bretonnet A.S., Krimm I., Lancelin J.M., and Gagnieu M.C. F-ara-AMP is a substrate of cytoplasmic 5′-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. Nucleosides Nucleotides Nucleic Acids 25 (2006) 289-297
25. Seve P., Mackey J.R., Isaac S., Tredan O., Souquet P.J., Perol M., Cass C., and Dumontet C. cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer. Lung Cancer 49 (2005) 363-370
26. Pesi R., Micheli V., Jacomelli G., Peruzzi L., Camici M., Garcia-Gil M., Allegrini S., and Tozzi M.G. Cytosolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. NeuroReport 11 (2000) 1827-1831
27. Page T., Yu A., Fontanesi J., and Nyhan W.L. Developmental disorder associated with increased cellular nucleotidase activity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11601-11606
28. Kredich N.M., and Holmes E.W. The Metabolic Basis of Inherited Disease (1990), Mc Grow-Hill
29. Denli A.M., and Hannon G.J. RNAi: an ever-growing puzzle. Trends Biochem. Sci. 28 (2003) 196-201
30. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
31. Tuschl T. RNA interference and small interfering RNAs. Chembiochem 2 (2001) 239-245
32. de Souza Nascimento P., Alves G., and Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol. Rep. 16 (2006) 423-428
33. Sambrook J., and D.W. Russel. Preparation and transformation of competent E. coli using Calcium Chloride, Molecular cloning - A laboratory manual. 3th edition vol 1 (2001) 1.116-1.118
34. Curiel D. Use and application of adenovirus expression vectors. In: Spector D.L., Goldman R.D., and Leinwand L.A. (Eds). Cells - A laboratory manual CSH Laboratory Press vol 2 (1998), Cold Spring Harbor, NY 90.14-90.16
35. Micheli V., Sestini S., Rocchigiani M., Jacomelli G., Manzoni F., Peruzzi L., Gathof B.S., Zammarchi E., and Pompucci G. Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes. Life Sci. 64 (1999) 2479-2487
36. Ceruti S., Mazzola A., and Abbracchio M.P. Resistance of human astrocytoma cells to apoptosis induced by mitochondria-damaging agents: possible implications for anticancer therapy. J. Pharmacol. Exp. Ther. 314 (2005) 825-837
37. Chiarelli L.R., Fermo E., Zanella A., and Valentini G. Hereditary erythrocyte pyrimidine 5′-nucleotidase deficiency: a biochemical, genetic and clinical overview. Hematology 11 (2006) 67-72
38. Rampazzo C., Ferraro P., Pontarin G., Fabris S., Reichard P., and Bianchi V. Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation. J. Biol. Chem. 279 (2004) 17019-17026
39. Rampazzo C., Gazziola C., Ferraro P., Gallinaro L., Johansson M., Reichard P., and Bianchi V. Human high-Km 5′-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells. Eur. J. Biochem. 261 (1999) 689-697
40. Balestri F., Giannecchini M., Sgarrella F., Carta M.C., Tozzi M.G., and Camici M. Purine and pyrimidine nucleosides preserve human astrocytoma cell adenylate energy charge under ischemic conditions. Neurochem. Int. 50 (2007) 517-523
41. Barsotti C., Pesi R., Felice F., and Ipata P.L. The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles. Cell. Mol. Life Sci. 60 (2003) 786-793
42. Tozzi M.G., Camici M., Mascia L., Sgarrella F., and Ipata P.L. Pentose phosphates in nucleoside interconversion and catabolism. FEBS J. 273 (2006) 1089-1101